Implantable Biodegradable Sponges: Effect of Interpolymer Complex Formation of Chitosan With Gelatin on the Release Behavior of Tramadol Hydrochloride

• Published in: Drug development and industrial pharmacy Vol. 33; no. 1; pp. 7 - 17
• Main Authors: Foda, Nagwa H., El-laithy, Hanan M., Tadros, Mina I.
• Format: Journal Article
• Language: English
• Published: Colchester Informa UK Ltd 2007; Taylor & Francis
• Subjects: Analgesics, Opioid - administration & dosage; Biological and medical sciences; Chitosan - administration & dosage; Controlled release; Cross-linking; Drug Implants; Gelatin - administration & dosage; Gelatin Sponge, Absorbable - administration & dosage; General pharmacology; Medical sciences; Microscopy, Electron, Scanning; Pharmaceutical technology. Pharmaceutical industry; Pharmacology. Drug treatments; Solubility; Spectroscopy, Fourier Transform Infrared; Sponges; Stable foams; Tramadol - administration & dosage; Tramadol - chemistry; Tramadol hydrochloride; Pharmaceutical technology; Biodegradability; Controlled release form; Animal origin; Crosslinking; Sponges; Marine environment; Tramadol hydrochloride; Analgesic; Gelatin; Porifera; Cross-linking; Tramadol; Dosage form; Stable foams; Chitosan; Behavior; Invertebrata; Release; Controlled release
• ISSN: 0363-9045; 1520-5762
• DOI: 10.1080/03639040600975188

ABSTRACT The effect of interpolymer complex formation between positively charged chitosan and negatively charged gelatin (Type B) on the release behavior of tramadol hydrochloride from biodegradable chitosan-gelatin sponges was studied. Mixed sponges were prepared by freeze-drying the cross-linked homogenous stable foams produced from chitosan and gelatin solutions where gelatin acts as a foam builder. Generation of stable foams was optimized where concentration, pH of gelatin solution, temperature, speed and duration of whipping process, and, chitosan-gelatin ratio drastically affect the properties and the stability of the produced foams. The prepared sponges were evaluated for their morphology, drug content, and microstructure using scanning electron microscopy, mechanical properties, uptake capacity, drug release profile, and their pharmacodynamic activity in terms of the analgesic effect after implantation in Wistar rats. It was revealed that whipping 7% (w/w) gelatin solution, of pH 5.5, for 15 min at 25°C with a stirring speed of 1000 rpm was the optimum conditions for stable gelatin foam generation. Moreover, homogenous, uniform chitosan-gelatin foam with small air bubbles were produced by mixing 2.5% w/w chitosan solution with 7% w/w gelatinsolution in 1:5 ratio. Indeed, polyionic complexation between chitosan and gelatin overcame the drawbacks of chitosan sponge mechanical properties where, pliable, soft, and compressible sponge with high fluid uptake capacity was produced at 25°Cand 65% relative humidity without any added plasticizer. Drugreleasestudies showed a successful retardation of the incorporated drug where the t50% values of the dissolution profiles were 0.55, 3.03, and 4.73 hr for cross-linked gelatin, un-cross-linked chitosan-gelatin, and cross-linked chitosan-gelatin sponges, respectively. All the release experiments followed Higuchi's diffusion mechanism over 12 hr. The achieved drug prolongation was a result of a combined effect of both cross-linking and polyelectrolyte complexation between chitosan and gelatin. The analgesic activity of the implanted tramadol hydrochloride mixed chitosan-gelatin sponge showed reasonable analgesic effect that was maintained for more than 8 hr. Therefore, the use of chitosan and gelatin together appears to allow the formulator to manipulate both the drug release profiles and the mechanical properties of the sponge that could be effectively implanted.